{
  "docId": "019de070-0ed4-7638-a889-7a7fc1ddc308",
  "docSlug": "5ce7ec09cf381a935cffcd873943f8c1",
  "documentTitle": "Aeglea BioTherapeutics | Results Presentation Deck | 13 slides",
  "authorId": "aeglea-biotherapeutics",
  "authorName": "Aeglea BioTherapeutics",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 10,
  "pageCount": 13,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "key_takeaways",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "The 'R' icon denotes patients who achieved >=1 MCID improvement.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-0ed4-7638-a889-7a7fc1ddc308/10",
  "deckHref": "/decks/019de070-0ed4-7638-a889-7a7fc1ddc308",
  "deckJsonHref": "/decks/019de070-0ed4-7638-a889-7a7fc1ddc308.json",
  "deckAnchorHref": "/decks/019de070-0ed4-7638-a889-7a7fc1ddc308#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.05,
        "y": 0.18
      },
      "kind": "chart",
      "text": "GMFM-D Change from Baseline 56 Week Analysis (n=6)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c31da941-1d0b-4c9a-872a-62d60e1a0579",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.6,
        "w": 0.45,
        "x": 0.55,
        "y": 0.18
      },
      "kind": "chart",
      "text": "GMFM-E change from Baseline 56 Week Analysis (n=6)",
      "attrs": null,
      "subkind": "bar-vertical",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d095661c-a13f-4f66-a7ec-cac7ef5dfd97",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.9,
        "x": 0.05,
        "y": 0.91
      },
      "kind": "disclaimer",
      "text": "MCID for GMFM Part D is 3.3 and 1.5 for GMFCS Levels II and III, respectively; MCID for GMFM Part E is 2.8 and 1.8 for GMFCS Levels II and III, respectively. Maximum values for GMFM-D and GMFM-E are 39 and 72, respectively.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2b5d7603-dc71-4c75-968c-428742887c78",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.2,
        "x": 0.25,
        "y": 0.86
      },
      "kind": "legend",
      "text": "R = >=1MCID Improvement",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9d1ede47-ccbc-4960-9a78-d1117f5c0d31",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.9,
        "x": 0.05,
        "y": 0.05
      },
      "kind": "title",
      "text": "Patients in GMFCS Levels II and III also Show Improvement in Mobility",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "75b8621c-995c-4ab0-b598-094ee7dd1959",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Waterfall chart",
      "slug": "waterfall-chart",
      "agent": null,
      "layer": "slide",
      "matchId": "2f551f20-71ed-4ac9-a8e0-fe62a4739359",
      "evidence": "chart/waterfall showing bridge from Q1 2019 to Q1 2020 Adj. EBITDA",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 11,
      "from": 5,
      "beatId": "ab1a9bb2-2594-47ca-80cf-39fc8cef5a32",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Solution",
      "beatSlug": "problem-agitate-solution-solution-provide-relief",
      "evidence": "The presentation showcases Pegzilarginase as a solution",
      "position": 2,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}